190 related articles for article (PubMed ID: 26727500)
1. Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.
Sato KA; Hachiya T; Iwaya T; Kume K; Matsuo T; Kawasaki K; Abiko Y; Akasaka R; Matsumoto T; Otsuka K; Nishizuka SS
PLoS One; 2016; 11(1):e0146275. PubMed ID: 26727500
[TBL] [Abstract][Full Text] [Related]
2. Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma.
Thomsen CB; Hansen TF; Andersen RF; Lindebjerg J; Jensen LH; Jakobsen A
J Exp Clin Cancer Res; 2018 Mar; 37(1):55. PubMed ID: 29530101
[TBL] [Abstract][Full Text] [Related]
3. The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues.
Yang N; Li Y; Liu Z; Qin H; Du D; Cao X; Cao X; Li J; Li D; Jiang B; Duan L; Yang H; Zhang Z; Lin H; Li J; Yang Z; Xiong L; Shen H; Lin L; Li F
BMC Cancer; 2018 Mar; 18(1):319. PubMed ID: 29566644
[TBL] [Abstract][Full Text] [Related]
4. Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer.
Dobilas A; Chen Y; Brueffer C; Leandersson P; Saal LH; Borgfeldt C
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):763-770. PubMed ID: 38035709
[TBL] [Abstract][Full Text] [Related]
5. Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors.
Li J; Jiang W; Wei J; Zhang J; Cai L; Luo M; Wang Z; Sun W; Wang S; Wang C; Dai C; Liu J; Wang G; Wang J; Xu Q; Deng Y
J Transl Med; 2020 Aug; 18(1):293. PubMed ID: 32738923
[TBL] [Abstract][Full Text] [Related]
6. Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity.
Huang A; Zhang X; Zhou SL; Cao Y; Huang XW; Fan J; Yang XR; Zhou J
J Cancer; 2016; 7(13):1907-1914. PubMed ID: 27698932
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer.
Boutin M; Topham JT; Feilotter H; Kennecke HF; Couture F; Harb M; Kavan P; Berry S; Lim HJ; Goffin JR; Ahmad C; Lott A; Renouf DJ; Jonker DJ; Tu D; O'Callaghan CJ; Chen EX; Loree JM
Ther Adv Med Oncol; 2023; 15():17588359231183682. PubMed ID: 37389190
[TBL] [Abstract][Full Text] [Related]
8. Highly multiplexed quantifications of 299 somatic mutations in colorectal cancer patients by automated MALDI-TOF mass spectrometry.
Xu C; Peng D; Li J; Chen M; Hu Y; Hou M; Shang Q; Liang Q; Li J; Li W; Wu X; Liu C; Hu W; Cai M; Zhang H; Chen G; Yu L; Zheng X; Jiang F; Luan J; Jin S; Ding C
BMC Med Genomics; 2020 Oct; 13(1):143. PubMed ID: 33008377
[TBL] [Abstract][Full Text] [Related]
9. Quantification of rare somatic single nucleotide variants by droplet digital PCR using SuperSelective primers.
Pablo-Fontecha V; Hernández-Illán E; Reparaz A; Asensio E; Morata J; Tonda R; Lahoz S; Parra C; Lozano JJ; García-Heredia A; Martínez-Roca A; Beltran S; Balaguer F; Jover R; Castells A; Trullàs R; Podlesniy P; Camps J
Sci Rep; 2023 Nov; 13(1):18997. PubMed ID: 37923774
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy with droplet digital PCR targeted to specific mutations in plasma cell-free tumor DNA can detect ovarian cancer recurrence earlier than CA125.
Minato T; Ito S; Li B; Fujimori H; Mochizuki M; Yamaguchi K; Tamai K; Shimada M; Tokunaga H; Shigeta S; Sato I; Shima H; Yamada H; Yaegashi N; Yasuda J
Gynecol Oncol Rep; 2021 Nov; 38():100847. PubMed ID: 34557579
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Mutated KRAS and Methylated HOXA9 Tumor-Specific DNA in Advanced Lung Adenocarcinoma.
Wen SWC; Andersen RF; Petersen LMS; Hager H; Hilberg O; Jakobsen A; Hansen TF
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322500
[TBL] [Abstract][Full Text] [Related]
12. Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression.
Moss EL; Gorsia DN; Collins A; Sandhu P; Foreman N; Gore A; Wood J; Kent C; Silcock L; Guttery DS
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32785174
[TBL] [Abstract][Full Text] [Related]
13. Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine.
Kahana-Edwin S; Torpy J; Cain LE; Mullins A; McCowage G; Woodfield SE; Vasudevan SA; Shea DPT; Minoche AE; Espinoza AF; Kummerfeld S; Goldstein LD; Karpelowsky J
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201440
[TBL] [Abstract][Full Text] [Related]
14. Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma.
Sandberg E; Nunes L; Edqvist PH; Mathot L; Chen L; Edgren T; Al Nassralla S; Glimelius B; Landegren U; Sjöblom T
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339300
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy.
Donnard E; Asprino PF; Correa BR; Bettoni F; Koyama FC; Navarro FC; Perez RO; Mariadason J; Sieber OM; Strausberg RL; Simpson AJ; Jardim DL; Reis LF; Parmigiani RB; Galante PA; Camargo AA
Oncotarget; 2014 Oct; 5(19):9199-213. PubMed ID: 25193853
[TBL] [Abstract][Full Text] [Related]
16. Intratumor heterogeneity in colorectal cancer: Distribution of tumor suppressor gene variants with regard to patient lymph node status.
Wątor G; Seweryn M; Kapusta P; Świrta J; Wałęga P; Barczyński M; Wołkow PP
Clin Genet; 2023 Oct; 104(4):406-417. PubMed ID: 37339860
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor DNA Response and Minimal Residual Disease Assessment in DNA Polymerase Epsilon-Mutated Colorectal Cancer Undergoing Immunotherapy.
Lutfi A; Afghan MK; Kasi PM
Cureus; 2023 Aug; 15(8):e43391. PubMed ID: 37593074
[TBL] [Abstract][Full Text] [Related]
18. ESR1 Mutations in Breast Cancer: Proof-of-Concept Challenges Clinical Action.
Gu G; Fuqua SA
Clin Cancer Res; 2016 Mar; 22(5):1034-6. PubMed ID: 26700205
[TBL] [Abstract][Full Text] [Related]
19. Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients.
Radefeldt M; Stellmacher-Kaiser S; Krake S; Kragl B; Lemke S; Beetz C; Bauer P; Junghanß C; Al-Ali R
Life (Basel); 2023 Nov; 13(12):. PubMed ID: 38137875
[TBL] [Abstract][Full Text] [Related]
20. Moss enables high sensitivity single-nucleotide variant calling from multiple bulk DNA tumor samples.
Zhang C; El-Kebir M; Ochoa I
Nat Commun; 2021 Apr; 12(1):2204. PubMed ID: 33850139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
